Tests a modified surgical device for removing bladder tumors
Tests a modified resectoscope to better study bladder tumors removed in adults with bladder cancer.
Key facts
- Who runs it
- National Cancer Institute (NCI)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
- Status
- Recruiting
- People taking part
- 25 people, planned
- Started
- 9 Sept 2020
- Expected to end
- 30 Sept 2029
- Type of study
- Observational
- Treatments tested
- modified resectoscope
- TURBT
- Record updated
- 29 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who need to have their bladder removed at the NIH Clinical Center. The removed bladder is cut with a modified device.
- Age
- 18 years and older.
- Sex
- Men and women can join.
- Disease stage
- People who need surgical removal of the bladder, for bladder cancer (including invasive cancer) or for a benign condition. People with advanced disease can also join.
- Earlier treatment
- People having other treatments or taking part in other trials can still join.
Main reasons for not taking part
- Pregnant women cannot join.
- People not deemed clinically appropriate for the planned surgery cannot join.
- People who cannot understand and sign the written consent form cannot join.
The registry criteria, word for word
Show all 8 criteriaShow less
Who cannot take part
- Cystectomy during pregnancy would subject the fetus to significant risk of miscarriage or premature labor. For this reason, pregnant women are ineligible for this study
Other criteria
- INCLUSION CRITERIA:
- Patients requiring surgical removal of the bladder at the NIH Clinical Center; NOTE: Reasons for need for surgical removal of bladder include cancer or benign condition for which a surgeon determined surgical removal of the bladder is recommended. Patient's with invasive bladder cancer requiring cystectomy are eligible for enrollment. Bladder cancer remains the most common reason for cystectomy. Patients with clinical advanced disease and having other treatments/or participating in other trials remain eligible for enrollment in this study
- Men and women
- Age greater than or less than 18 years
- Deemed clinically appropriate for the planned surgical procedure
- Ability of subject to understand and the willingness to sign a written informed consent document
- Subjects will be asked to co-enroll in 15-C-0087, "Care of the Urothelial Cancer Patient and Prospective Collection of Biospecimens from Healthy Volunteers and Urothelial Cancer Patients." NOTE: Most participants are expected to already be enrolled in 15-C-0087 prior to entry in this study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 120 years old?
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: NCI Medical Oncology Referral OfficeTaking people
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
Bladder cancer is the sixth most common cancer in the United States. The way that doctors remove tumors in bladder surgeries may leave some cancer . Also, many people have their tumors return or progress after surgery. Researchers want to test a modified device. It might tell doctors more about bladder tumors.
Objective:
To see if using a modified standard device with bladder surgery can provide better information about tumors in bladder specimens.
Eligibility:
People ages 18 and older who need to have their bladder removed at the NIH.
Design:
Participants will be screened with:
Medical and prior surgical history
Review of existing MRI, x-ray, or CT scans
Review of existing specimens and reports
Pregnancy test for women of childbearing age
CT or MRI: Participants will lie in a machine. The machine will take pictures of their body.
Participants will have bladder surgery. This will occur in the same way as if they did not take part in this study. A member of the research team will cut the removed bladder using the modified device. This will most likely be done on a separate back table in the operating room. The bladder and samples after cutting will be sent out for review. The will occur just as it would if the participants were not in this study. The only difference is the way that the specimen is prepared for review.
Participants follow-up care will occur per standard of care. Or it will occur as part of any other study in which they might also be enrolled.
The group in the trial
- 1/ Cohort 1
Bladder Cancer Patients
Treatment: modified resectoscope and TURBT
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Ex-Vivo Trial of En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
- Plain-language title
- Tests a modified surgical device for removing bladder tumorsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04235764, who can take part
- Record updated
- 29 October 2026